Clinical Trial

Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Bromelain, a natural product, exhibits anti-inflammatory, immunomodulatory, and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to evaluate the effect of bromelain as a safe alternate for management of RAS.
Trial Details
NCT Number NCT06993337
Lead Sponsor Cairo University
Conditions Recurrent Aphthous Stomatitis
Enrollment 63 participants
Start Date 2025-06-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-28